Proceedings.

Tanta Pharmaceuticals Inc.

ActiveFollow
Proceeding
NOIsubsection 50.4 (1) of the Bankruptcy and Insolvency Act
File
BK-23-2933296-00313
Filings held13
Last activity16 Feb 2024
On the record1,302 days
OverviewSummary updated

Tanta Pharmaceuticals Inc. filed a notice of intention to make a proposal under subsection 50.4(1) of the Bankruptcy and Insolvency Act on April 13, 2023, with B. Riley Farber Inc. as licensed insolvency trustee. The proceeding is before the Ontario Superior Court of Justice (in Bankruptcy and Insolvency) under estate number 31-2933296 and court file BK-23-2933296-00313, and remains active. The Form 33 list of creditors with claims of $250 or more, prepared as at the NOI filing date, is headed by 1000393782 Ontario Inc. at $4,184,111.25, followed by Prasanna Tanna at $761,938.51 and a shareholder's loan of $377,773.19 owing to Bhavanesh Tanna, both related-party claims. CRA deemed trust claims are listed at $181,055.90, $120,855.78, $44,728.49 and $23,120.17, alongside $244,970.00 to the Business Development Bank of Canada, $145,000.00 to Avanti Rx Analytics Inc and a $60,000.00 BMO CEBA loan.

Ask in plain language. The answer comes only from this case’s filings, each one cited.
Enter to send · Shift+Enter for a new line
Open this case in Proceedings AI⁠Save your chats, keep long conversations going, and ask across every case.
Case updates12 dated entries · 1 undated
Undated filings1 — no date appears on the document · show
—
Report

Report of Trustee on Proposal — Court officer report filed

Parties

Debtor

Tanta Pharmaceuticals Inc.

Proposal trustee

B. Riley Farber

Bench and counselPer the orders and service lists on the record

Bench

JudgeCourtOn this docketCases on record
Justice PennyOntario Superior Court of Justice2 orders, Aug 2023196 cases on record

Counsel of record

PartyCounselFirst seenSource
Proposal trusteeB. Riley Farber IncLoopstra Nixon LLP16 Aug 2023Order · 16 Aug 2023
Capital structureAs asserted in the filings
stated amounts, drawn to scale · for subscribers
Priority classCreditorAmountSource
Unsecured1000393782 Ontario Inc.as of NOI filing date — debtor: Tanta Pharmaceuticals Inc.$4.18MNOI Creditors Package
Unsecured
Unsecured
Unsecured
Unsecured
Unsecured
Unsecured
Unsecured
Unsecured
Unsecured

37 more claims in 1 class The stack holds Unsecured claims.

Every creditor and every amount, drawn to scale.

Start 5-day trial

Card required. Nothing charged for 5 days. Cancel anytime.

Already a subscriber? Sign in.

See all plans⁠
RecoveriesAs stated in the filings

Unsecured creditors: paid in full. Sigma no distribution.Under the plan · implementedOrder of Justice Penny Approving Proposal · 16 Aug 2023

ClassCreditorClaimsRecoveryBasisSource
Deemed trust——paid in fullUnder the planimplementedper the courtOrder of Justice Penny Approving Proposal · 16 Aug 2023
Preferred——paid in fullUnder the planimplementedper the courtOrder of Justice Penny Approving Proposal · 16 Aug 2023
UnsecuredConvenience Creditor Claims—paid in fullUnder the planimplementedper the courtOrder of Justice Penny Approving Proposal · 16 Aug 2023
UnsecuredSigmarelated party—no distributionUnder the planimplementedper the courtOrder of Justice Penny Approving Proposal · 16 Aug 2023
EquityRelated Parties, Existing Equity Holders and Sigmarelated party—no distributionUnder the planimplementedper the proposal trusteeProposal Creditors Package · 18 May 2023
EquityRelated Parties, Existing Equity Holders, Sigmarelated party—no distributionUnder the planimplementedper the courtOrder of Justice Penny Approving Proposal · 16 Aug 2023

Each row is one filing's statement, copied as it reads and never computed. "Estimated" is the officer's forecast; "Under the plan" is the plan's or proposal's own term; "Final" is a declared or paid distribution; a row with no chip states no footing. A range is the two numbers stated; "of proven claims" is the document's own denominator.

Estate financialsReported figures — never derived
Total assets at filing
Total liabilities at filing

As at ·

The 2 totals the debtor stated at filing

Each one as the filing states it, with its source.

Start 5-day trial

Card required. Nothing charged for 5 days. Cancel anytime.

Already a subscriber? Sign in.

See all plans⁠
Documents
13 filings
DateDocumentFile
Certificate of Full Performance (Form 46)PDF · Subscribers
Endorsement of Justice Penny
  • Presiding officer Justice Penny
PDF · Subscribers
Order of Justice Penny Approving Proposal
  • Counsel Loopsra Nixon LLP
  • Court SUPERIOR COURT OF JUSTICE
  • Court file no BK-23-2933296-00313
  • Presiding officer Justice Penny
  • + 2 more extracted facts
PDF · Subscribers
Notice of Hearing of Application for Court ApprovalPDF · Subscribers
Minutes of Reconvened Meeting of Creditors
PDF · Subscribers
Amended Certificate of Filing of a ProposalPDF · Subscribers
Certificate of Filing of a ProposalPDF · Subscribers
Notice of Reconvening of Creditors Meeting
  • Financial position · Secured creditors · Unsecured creditors Subscribers
PDF · Subscribers
Minutes of Meeting of Creditors to Consider Proposal
PDF · Subscribers
Proposal Creditors Package
  • Commencement date 13 April 2023
  • Court SUPERIOR COURT OF JUSTICE (IN BANKRUPTCY AND INSOLVENCY)
  • Recovery outcome Entries: per plan; per plan; per plan; per plan; per plan; per liquidation_alternative · Stated on: 2023-05-18 · Table missing:
  • Financial position Subscribers
PDF · Subscribers
NOI Creditors Package
  • Province Ontario
  • Financial position · Secured creditors · Unsecured creditors Subscribers
PDF · Subscribers
Certificate of Filing of a Notice of Intention to Make a Proposal
  • Appointee B. Riley Farber Inc.
  • Appointee role Licensed Insolvency Trustee
  • Commencement date 13 April 2023
  • Court file no 31-2933296
  • + 2 more extracted facts
PDF · Subscribers
Report of Trustee on ProposalTrustee site

Filing titles and dates are public, and so is each filing's own page. The figures read from them are for subscribers.

CiteProceedings., “Tanta Pharmaceuticals Inc.” (NOI), Ontario Superior Court of Justice. Retrieved 5 November 2026, https://proceedings.ca/case/tanta-pharmaceuticals-inc

Sources last checked · summary updated 19 August 2026 · Report a correction · Printed from proceedings.ca/case/tanta-pharmaceuticals-inc

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.